Drugmakers are facing mounting calls to give up their patent rights for potentially life-saving treatments and vaccines for coronavirus as authorities worldwide race to curb the pandemic’s death toll.

The heads of the World Health Organization and Unitaid, a UN-backed group funding global health innovation, have welcomed a proposal devised by Costa Rica for companies voluntarily to pool their intellectual property for all medical interventions — including treatment, vaccines and diagnostics.

In a statement, the WHO said it was committed to equitable access, including for interventions related to Covid-19, the disease caused by the novel coronavirus.

Big drugmakers under pressure to share patents against coronavirus via @financialtimes

April 02, 2020
patent IP WHO news COVID19 Pandemic